Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
Roche announced June 27 that the U.S. FDA has issued 510(k) clearance for the company's CSF Aβ42/total-tau assay to be used for the diagnosis of Alzheimer’s disease in people aged 55 and older. The ...
The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...
Using single-cell sequencing, researchers found distinct immune profiles in different CNS tumors, highlighting its potential as a prognostic tool.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results